BYLVAY Trademark

Trademark Overview

On Tuesday, May 26, 2020, a trademark application was filed for BYLVAY with the United States Patent and Trademark Office. The USPTO has given the BYLVAY trademark a serial number of 88932949. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Albireo AB. The BYLVAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders
bylvay

General Information

Serial Number88932949
Word MarkBYLVAY
Filing DateTuesday, May 26, 2020
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6489166
Registration DateTuesday, September 21, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlbireo AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGöteborg 41346
SE
Party NameAlbireo AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGöteborg 41346
SE
Party NameAlbireo AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGöteborg 41346
SE

Trademark Events

Event DateEvent Description
Friday, June 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 29, 2020NEW APPLICATION ENTERED
Wednesday, August 26, 2020ASSIGNED TO EXAMINER
Wednesday, August 26, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, August 26, 2020SUSPENSION LETTER WRITTEN
Wednesday, August 26, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 26, 2021SUSPENSION INQUIRY WRITTEN
Friday, February 26, 2021INQUIRY TO SUSPENSION E-MAILED
Friday, February 26, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, February 26, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 27, 2021ASSIGNED TO LIE
Friday, May 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 28, 2021EXAMINERS AMENDMENT E-MAILED
Friday, May 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 28, 2021EXAMINER'S AMENDMENT ENTERED
Friday, May 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Friday, May 28, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, March 23, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 23, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, March 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

bylvay diseases disorders gastrointestinal liver product treatment pharmaceutical